OxyContin maker, execs hit with fine
OxyContin maker Purdue Pharma and three of its executives were ordered to pay a $634.5-million fine for misleading the public about the painkiller’s risk of addiction.
U.S. District Judge James Jones in Virginia levied the fine on Purdue, its top lawyer and former president and former chief medical officer. The judge heard from numerous people who said their lives were changed by addiction to OxyContin, a trade name for a long-acting form of the painkiller oxycodone.
From 1996 to 2001, the number of oxycodone-related deaths nationwide increased fivefold while the annual number of prescriptions rose nearly 20-fold.
The executives pleaded guilty in May. The sentencing ends a long-running national case.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
